Lv2
190 积分 2023-11-21 加入
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
4个月前
已完结
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
4个月前
已完结
Immunotherapy in mismatch repair-deficient metastatic colorectal cancer – Outcome and novel predictive markers
4个月前
已完结
Prognostic Impact of Hepatic Steatosis Evaluated by CT on Immunotherapy for Gastric Cancer: Associations with Sarcopenia, Systemic Inflammation, and Hormones
5个月前
已完结
Immune checkpoint inhibitors for patients with isolated peritoneal carcinomatosis from dMMR/MSI-H colorectal cancer, a BIG-RENAPE collaboration
9个月前
已完结
Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting
9个月前
已完结
Duration of Immunotherapy in dMMR/MSI-H Metastatic Colorectal Cancer Patients
9个月前
已完结
皖公网安备34019202002308
